Written by Dr. Ryan Kneessi, ND
Quick answer: Cocoa flavanols are plant compounds found in cocoa beans and, in smaller amounts, in tea, apples, berries, and grapes. The COSMOS trial gave more than 21,000 older adults a daily cocoa extract with 500 mg of flavanols or a placebo for several years. The extract did not significantly change the main combined measure of cardiovascular events, but it was linked to fewer deaths from cardiovascular disease, a slower age-related rise in the inflammation marker hsCRP, better memory scores in people whose usual diets were lower in quality or in flavanols, and fewer new cases of high blood pressure in people whose systolic pressure started below 120 mm Hg. These were mostly secondary or subgroup findings, so they are encouraging rather than settled.
Taking a lot of supplements and not sure what's worth it?
Send me your list for a free supplement review. There is no cost and no appointment needed.
Key takeaways
In the main COSMOS trial of 21,442 older adults followed for a median of 3.6 years, a daily cocoa extract with 500 mg of flavanols did not significantly lower total cardiovascular events (hazard ratio 0.90), but deaths from cardiovascular disease were 27 percent lower than with placebo.
In a two-year COSMOS blood study of 598 participants, hsCRP rose about 5.5 percent per year on placebo, while the cocoa extract group showed no significant rise, for a between-group difference of about 8.4 percent per year. IL-6, TNF-alpha, and IL-10 did not change significantly overall.
In COSMOS-Web, which tested memory online in 3,562 older adults, the main one-year memory comparison was not statistically significant, but memory scores improved with the cocoa extract in people whose habitual diet quality or flavanol intake was lowest at the start.
Among 8,905 participants without high blood pressure at the start, the cocoa extract did not change the overall rate of new high blood pressure, but people whose systolic pressure began below 120 mm Hg had about 24 percent fewer new cases than those on placebo.
Cocoa has a long history as a food that people enjoy and an equally long history of being oversold. A chocolate bar is not a health food, and most of what is sold as chocolate contains far more sugar and fat than flavanols. Still, the compounds that give raw cocoa its bitter edge have been studied seriously for years, and the largest trial ever run on them, the COcoa Supplement and Multivitamin Outcomes Study (COSMOS), has now produced several papers worth reading carefully.
I have already written about the multivitamin side of this same trial in my review of multivitamins and memory in the COSMOS studies. Here I want to focus on the cocoa side. I will walk through four free, peer-reviewed papers: the main cardiovascular results, a two-year study of inflammation markers, an online memory study, and a newer analysis of high blood pressure. Each paper has real strengths and real limits, and the details matter more than the headlines.
What cocoa flavanols are and why aging researchers care
Flavanols are a family of polyphenols, the plant compounds that give many fruits, teas, and cocoa their color and astringent taste. The flavanol most studied in cocoa is epicatechin. In shorter trials, cocoa flavanols have been linked to better function of the inner lining of blood vessels, partly through nitric oxide signaling, which helps arteries relax and widen. That vascular effect is one reason researchers wondered whether long-term intake might matter for heart health, blood pressure, and blood flow to the brain.
There is also an aging angle. One of the recognized hallmarks of aging is a slow, low-grade rise in background inflammation, often called inflammaging, which I explain in more depth in this overview of inflammaging. Changes in blood vessels and in how cells signal to one another sit right next to that process. If a dietary compound could nudge vascular function and inflammation in a better direction over years, it would be relevant to healthy aging even if it never made a dramatic difference on its own.
The first study: the main COSMOS cardiovascular results
The first paper, published in 2022 in The American Journal of Clinical Nutrition by Howard Sesso, JoAnn Manson, and colleagues, reported the main cardiovascular results of the cocoa arm of COSMOS. The trial enrolled 21,442 adults in the United States, women aged 65 and older and men aged 60 and older, who had no major cardiovascular disease and no recent cancer at the start. Participants were randomly assigned to a daily cocoa extract supplement providing 500 mg of flavanols, including 80 mg of epicatechin, or to a placebo, and the design also tested a multivitamin at the same time.
Over a median follow-up of 3.6 years, 410 people in the cocoa extract group and 456 in the placebo group had a confirmed cardiovascular event. That difference produced a hazard ratio of 0.90, which was not statistically significant for the main combined outcome. For the secondary outcome of death from cardiovascular disease, the hazard ratio was 0.73, which corresponds to the 27 percent lower rate that drew headlines. Heart attack, stroke, and procedures to open arteries did not differ significantly on their own. When the researchers looked only at people while they were taking their study pills as directed, the reduction in total cardiovascular events became statistically significant, with a hazard ratio of 0.85. The authors reported no safety concerns.
This is a large, double-blind, placebo-controlled trial, which is exactly the kind of evidence nutrition research often lacks. Its main outcome was still not significant, though, and secondary findings can be chance results even in big trials. The authors themselves called for more research rather than declaring a benefit. I read this paper as a careful signal worth following, not as a reason to start a supplement.
The second study: cocoa extract and inflammation markers over two years
The second paper, published in 2025 in Age and Ageing by Sidong Li, Rikuta Hamaya, Howard Sesso, Yanbin Dong, and colleagues, asked a mechanistic question. If cocoa extract was linked to fewer cardiovascular deaths, did it also change the inflammation markers that tend to creep upward with age? The team measured five blood markers at the start, after one year, and after two years in a random sample of 598 COSMOS participants with an average age of 70. The markers were hsCRP, interleukin-6, tumor necrosis factor-alpha, interleukin-10, and interferon-gamma.
In the placebo group, hsCRP rose by about 5.5 percent per year, which fits the usual pattern of inflammaging. In the cocoa extract group, hsCRP did not rise significantly, and the difference between groups was about 8.4 percent per year, which remained significant after the authors adjusted for testing several markers. Interferon-gamma, an immune messenger with both protective and inflammatory roles, rose modestly with cocoa extract. Interleukin-6, tumor necrosis factor-alpha, and interleukin-10 did not change significantly overall. In secondary analyses, interleukin-6 appeared to move differently in women than in men and fell in participants who had diabetes at the start.
These are the same markers I discuss in my articles on hsCRP, IL-6, and TNF-alpha, so it is interesting to see them tracked in a long trial. The limits are important. The sample was mostly non-Hispanic White older adults, the people chosen stayed free of cardiovascular events during the study, and only one of the three main inflammatory markers clearly changed. The study supports the idea that cocoa flavanols may influence inflammaging, but it does not show that lower hsCRP explains the cardiovascular findings.
The third study: memory and the quality of the usual diet
The third paper, published in 2023 in the Proceedings of the National Academy of Sciences by Adam Brickman, Scott Small, and colleagues at Columbia University, came from COSMOS-Web, a part of the trial in which 3,562 older adults completed memory tests online each year for three years. The researchers focused on a type of memory that depends on the hippocampus, the brain region that helps us learn and recall new information, and they measured habitual diet quality with a standard healthy eating score. In 1,361 participants, they also measured a urine marker that reflects how many flavanols a person usually eats.
The main question, whether cocoa extract improved this memory score across everyone after one year, did not reach statistical significance. The more interesting result came from the planned secondary analysis. People in the lowest third of habitual diet quality, and people in the lowest third of the urine flavanol marker, showed better memory scores with cocoa extract than with placebo, and that difference appeared to hold over the three years. People who already ate well did not show the same change. Rising levels of the flavanol marker during the trial also tracked with improving memory.
The authors describe this as a depletion and repletion pattern, much like a vitamin that matters most when intake is low. The effect sizes were small, the testing was done at home on a computer, and most participants were White and well educated, so the findings may not apply to everyone. It fits with what I see in the research on olive oil and brain aging and on brain health and cognitive aging: the overall pattern of the diet seems to matter at least as much as any single compound.
The fourth study: new high blood pressure over several years
The fourth paper, published in 2025 in Hypertension by Rikuta Hamaya, Howard Sesso, and colleagues, looked at 8,905 COSMOS participants who did not report high blood pressure at the start. New high blood pressure was defined as a physician telling the participant for the first time that they had high blood pressure, starting blood-pressure medication, or a reported elevated reading. The average age was 71, and the median follow-up was 3.4 years.
Across the whole group, cocoa extract made no meaningful difference. New high blood pressure occurred at a rate of 7.1 per 100 person-years with cocoa extract and 7.4 with placebo, a hazard ratio of 0.96. The picture changed when the researchers split people by their starting systolic pressure. Among those who began below 120 mm Hg, the cocoa extract group had about 24 percent fewer new cases than the placebo group, and the difference became visible around the second year. Among those who began between 120 and 139 mm Hg, there was no benefit. Results were similar when the authors used different definitions of high blood pressure.
Blood pressure was mostly self-reported rather than measured at study visits, and subgroup findings always need confirmation in a new trial. Even so, the result is a useful reminder that a modest dietary factor may matter most early, before blood pressure has started to climb, rather than as a substitute for proven approaches once it has. If blood pressure is your focus, I have also reviewed trials of tai chi for blood pressure, sleep, and balance.
How to read these results together
Taken together, the cocoa arm of COSMOS tells a consistent but modest story. The main cardiovascular outcome did not reach significance, while death from cardiovascular disease, a slower rise in hsCRP, memory in people with lower-quality diets, and new high blood pressure in people with normal starting pressure all leaned in a favorable direction. Every one of those findings is a secondary or subgroup result, and that is exactly why careful researchers describe them as promising rather than proven.
It is also important to be clear about what was tested. COSMOS used a standardized cocoa extract capsule with a known flavanol dose, not chocolate, cocoa drinks, or desserts. Participants were allowed to eat chocolate as usual, and the trial did not study chocolate as a food. Commercial chocolate varies widely in flavanol content because processing, including the alkalizing step used for many cocoa powders, can strip out much of it, and chocolate brings sugar and calories that the capsules did not.
How I think about this as a functional medicine doctor
When I look at research like this, I pay the most attention to the memory finding, because it lines up with something I see constantly in practice. Nutrients and plant compounds tend to matter most for people whose diets are missing them. Instead of starting with a capsule, I usually start with the overall eating pattern and ask whether flavanol-rich foods such as tea, apples, berries, grapes, and minimally processed cocoa show up regularly, along with the vegetables, olive oil, legumes, and fish that make up a broader anti-inflammatory way of eating.
Labs can help make the conversation concrete. Markers such as hsCRP and IL-6 give a rough sense of inflammatory load, and blood pressure, blood sugar markers, and lipids round out the cardiovascular picture. None of these numbers tells the whole story on its own, and none of them should be chased with a single food or supplement. They are most useful as a baseline and a way to see whether a broader plan is moving in the right direction over time.
If you would like to talk through how diet quality, inflammation markers, and healthy aging fit together for you, I offer a free 15-minute consultation where we can decide whether working together makes sense for you.
Frequently asked questions
What are cocoa flavanols?
Cocoa flavanols are polyphenols found naturally in cocoa beans. The best-studied one is epicatechin. Flavanols are also found in tea, apples, berries, grapes, and other plant foods, and they have been studied mainly for their effects on blood vessel function, blood pressure, and memory.
Does eating chocolate give the same results as the COSMOS studies?
Not necessarily. COSMOS tested a standardized cocoa extract providing 500 mg of flavanols a day, not chocolate. Flavanol content in chocolate and cocoa powder varies widely with processing, and chocolate adds sugar and calories, so the trial results cannot be applied directly to chocolate.
Who seemed to show the clearest changes in these studies?
In the memory study, the clearest changes were in people whose usual diets were lowest in quality or in flavanols. In the blood pressure study, the clearest changes were in people whose systolic pressure started below 120 mm Hg. Both were subgroup findings that need to be confirmed in future trials.
Should I take a cocoa extract supplement?
That depends on your health history, your medications, and the rest of your diet. The COSMOS results are encouraging but mostly secondary, and a food-first approach is usually the best place to begin. Talk with your own clinician before adding any supplement, especially if you take blood pressure or blood-thinning medication.
Sources
This article is for educational purposes only and is not medical advice. It does not replace an individual evaluation. Talk with your healthcare provider before making changes to your diet, exercise, supplements, or medications, especially if you are pregnant, nursing, or managing a health condition.


